VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ARTL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ARTLArtelo Biosciences, Inc.
$1.12$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksARTLQuarterly Financials

Artelo Biosciences, Inc. (ARTL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Artelo Biosciences, Inc. (ARTL) quarterly income statement — complete revenue, gross profit & net income history

ARTL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses2.69M2.79M3.09M3.15M2.38M3.81M1.2M2.51M2.59M3.24M2.61M1.78M2.29M3.48M2.39M2.47M1.95M2.55M1.89M2.25M
OpEx % of Revenue--------------------
Selling, General & Admin1.92M1.89M1.81M1.28M995K1.34M870K827K1.08M1.12M1.03M1.03M1.06M1.75M1.32M1.42M1.48M1.28M1.27M1.3M
SG&A % of Revenue--------------------
Research & Development773K893K1.27M1.87M1.38M2.48M325K1.69M1.51M2.12M1.58M752K1.24M1.73M1.08M1.06M464K1.27M615.46K951.2K
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-2.69M-2.79M-3.09M-3.15M-2.38M-3.81M-1.2M-2.51M-2.59M-3.24M-2.61M-1.78M-2.29M-3.48M-2.39M-2.47M-1.95M-2.55M-1.89M-2.25M
Operating Margin %--------------------
Operating Income Growth %-13.03%26.91%-158.49%-25.4%8.11%-17.65%54.28%-40.81%-12.96%6.79%-9.19%27.8%-17.78%-36.21%-26.88%-9.75%-4.2%-77.72%-83.65%-136.64%
EBITDA-2.83M-3.79M-3.01M-3.15M-2.38M-3.81M-1.13M-2.43M-2.59M-3.07M-2.61M-1.78M-2.29M-3.34M-2.33M-2.47M-1.95M-2.55M-1.89M-2.25M
EBITDA Margin %--------------------
EBITDA Growth %-19.13%0.6%-165.81%-29.43%8.11%-24.05%56.69%-36.38%-12.96%7.97%-12.43%27.8%-17.78%-30.84%-23.22%-9.76%-4.21%-77.72%-83.68%-136.67%
D&A (Non-Cash Add-back)000000000000000000061
EBIT-2.83M-3.79M-3.01M-3.15M-2.38M-3.81M-1.13M-2.43M-2.59M-3.07M-2.61M-1.78M-2.29M-3.34M-2.33M-2.47M-1.95M-2.55M-1.89M-2.25M
Net Interest Income-123K-364K-106K-71K7K000000000-5K1K1K2K544636
Interest Income1K13K5K1K7K00000000001K1K2K544636
Interest Expense124K377K111K72K00000000005K00000
Other Income/Expense-269K-1.38M-31K-71K7K34K63K79K106K167K165K185K124K137K64K22K-19K4K2251.62K
Pretax Income-2.96M-4.17M-3.12M-3.22M-2.37M-3.78M-1.13M-2.43M-2.48M-3.07M-2.45M-1.6M-2.17M-3.34M-2.33M-2.45M-1.97M-2.55M-1.89M-2.25M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-2.96M-4.17M-3.12M-3.22M-2.37M-3.78M-1.13M-2.43M-2.48M-3.07M-2.45M-1.6M-2.17M-3.34M-2.33M-2.45M-1.97M-2.55M-1.89M-2.25M
Net Margin %--------------------
Net Income Growth %-24.7%-10.27%-175.62%-32.39%4.47%-22.94%53.78%-52.16%-14.53%7.97%-5.11%34.71%-10.33%-31.04%-23.5%-8.85%-5.31%-77.56%-83.67%-136.52%
Net Income (Continuing)-2.96M-4.17M-3.12M-3.22M-2.37M-3.78M-1.13M-2.43M-2.48M-3.07M-2.45M-1.6M-2.17M-3.34M-2.33M-2.45M-1.97M-2.55M-1.89M-2.25M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-4.00-2.04-1.32-1.87-0.24-2.33-0.12-0.25-0.26-1.93-0.28-0.19-0.24-0.38-0.26-0.29-0.23-0.42-0.02-0.49
EPS Growth %-1566.83%12.56%-1034.29%-648%7.69%-21.11%57.83%-33.93%-8.33%-411.5%-5.06%34.88%-2.86%10.32%-1174.19%41.1%57.58%40.28%38%64.56%
EPS (Basic)-4.00-2.04-1.32-1.87-0.24-2.33-0.12-0.25-0.26-1.93-0.28-0.19-0.24-0.38-0.26-0.29-0.23-0.42-0.02-0.49
Diluted Shares Outstanding739K2.36M2.36M1.72M9.84M1.62M9.68M9.68M9.59M1.59M1.47M1.43M1.43M1.42M1.42M1.42M1.41M1.01M1.01M770.36K
Basic Shares Outstanding739K2.36M2.36M1.72M9.84M1.62M9.68M9.68M9.59M1.59M1.47M1.43M1.43M1.41M1.42M1.41M1.41M1.01M1.01M770.36K
Dividend Payout Ratio--------------------